open access

Vol 5 (2020): Continuous Publishing
Case report
Published online: 2020-11-25
Get Citation

Progressive bilateral ocular ischemic syndrome despite previously performed carotid endarterectomy

Marta Świerczyńska12, Lech Sedlak12, Mariola Dorecka12
·
Ophthalmol J 2020;5:114-119.
Affiliations
  1. Department of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland
  2. Department of Ophthalmology, Kornel Gibiński University Clinical Center, Medical University of Silesia, Katowice, Poland, Poland

open access

Vol 5 (2020): Continuous Publishing
CASE REPORTS
Published online: 2020-11-25

Abstract

The ocular ischemic syndrome (OIS) is a rare condition with vision-threatening potentials. It is characterized by chronic ischemia of the anterior and/or posterior segment of the eye primarily caused by severe carotid artery occlusive diseases. In this article, we present a case of a 67-year-old male patient presented with the gradual diminution of vision in the right eye for 6 months. The patient had undergone a right internal carotid artery (ICA) endarterectomy (CEA) twice before. On the day of admission, intraocular pressure (IOP) was 34 mm Hg in the right eye (RE) and 20 mm Hg in the left eye (LE). On anterior segment examination, neovascularization of iris in the right eye was noted. On fundoscopy dilated retinal veins, attenuated retinal arteries, blot hemorrhages, cotton wool spots and microaneurysms were present. The patient underwent the appropriate investigations including computed tomography angiography (CTA) of carotid arteries, fundus fluorescence angiography (FFA) and Doppler ultrasound (DUS) of ophthalmic and central retinal arteries, which were all consistent with a diagnosis of bilateral OIS. Intraocular pressure was pharmacologically reduced and stabilized. Subsequently, panretinal photocoagulation (PRP) of peripheral capillary nonperfusion areas was performed in both eyes.

Abstract

The ocular ischemic syndrome (OIS) is a rare condition with vision-threatening potentials. It is characterized by chronic ischemia of the anterior and/or posterior segment of the eye primarily caused by severe carotid artery occlusive diseases. In this article, we present a case of a 67-year-old male patient presented with the gradual diminution of vision in the right eye for 6 months. The patient had undergone a right internal carotid artery (ICA) endarterectomy (CEA) twice before. On the day of admission, intraocular pressure (IOP) was 34 mm Hg in the right eye (RE) and 20 mm Hg in the left eye (LE). On anterior segment examination, neovascularization of iris in the right eye was noted. On fundoscopy dilated retinal veins, attenuated retinal arteries, blot hemorrhages, cotton wool spots and microaneurysms were present. The patient underwent the appropriate investigations including computed tomography angiography (CTA) of carotid arteries, fundus fluorescence angiography (FFA) and Doppler ultrasound (DUS) of ophthalmic and central retinal arteries, which were all consistent with a diagnosis of bilateral OIS. Intraocular pressure was pharmacologically reduced and stabilized. Subsequently, panretinal photocoagulation (PRP) of peripheral capillary nonperfusion areas was performed in both eyes.

Get Citation

Keywords

bilateral ocular ischemic syndrome; IOS; carotid artery occlusion; neovascular glaucoma

About this article
Title

Progressive bilateral ocular ischemic syndrome despite previously performed carotid endarterectomy

Journal

Ophthalmology Journal

Issue

Vol 5 (2020): Continuous Publishing

Article type

Case report

Pages

114-119

Published online

2020-11-25

Page views

511

Article views/downloads

512

DOI

10.5603/OJ.2020.0024

Bibliographic record

Ophthalmol J 2020;5:114-119.

Keywords

bilateral ocular ischemic syndrome
IOS
carotid artery occlusion
neovascular glaucoma

Authors

Marta Świerczyńska
Lech Sedlak
Mariola Dorecka

References (21)
  1. Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome. Surv Ophthalmol. 2010; 55(1): 2–34.
  2. Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome - a systematic review. Med Sci Monit. 2012; 18(8): RA138–RA144.
  3. Sharma S, Brown GC. Ocular Ischemic Syndrome. In: Ryan SJ, Hinton DR, Schachat AP. ed. Retina. Elsevier, New York 2006: 1491–1502.
  4. Luo J, Yan Z, Jia Yu, et al. Clinical Analysis of 42 Cases of Ocular Ischemic Syndrome. J Ophthalmol. 2018; 2018: 2606147.
  5. Hong IH, Ahn JK, Chang S, et al. Diagnostic efficacy of total homocysteine and C-reactive protein for ocular ischemic syndrome. Eye (Lond). 2011; 25(12): 1650–1654.
  6. Wang H, Wang Y, Li H. Multimodality Imaging Assessment of Ocular Ischemic Syndrome. J Ophthalmol. 2017; 2017: 4169135.
  7. Mizener J, Podhajsky P, Hayreh S. Ocular Ischemic Syndrome. Ophthalmology. 1997; 104(5): 859–864.
  8. Peter J, David S, Danda D, et al. Ocular manifestations of Takayasu arteritis: a cross-sectional study. Retina. 2011; 31(6): 1170–1178.
  9. Tang Y, Luo D, Peng W, et al. Ocular ischemic syndrome secondary to carotid artery occlusion as a late complication of radiotherapy of nasopharyngeal carcinoma. J Neuroophthalmol. 2010; 30(4): 315–320.
  10. Huang ZL, Lin KH, Lee YC, et al. Acute vision loss after intravitreal injection of bevacizumab (avastin) associated with ocular ischemic syndrome. Ophthalmologica. 2010; 224(2): 86–89.
  11. Chen CS, Miller NR. Ocular ischemic syndrome: review of clinical presentations, etiology, investigation, and management. Compr Ophthalmol Update. 2007; 8(1): 17–28.
  12. Kang HM, Choi JH, Koh HJ, et al. Significant changes of the choroid in patients with ocular ischemic syndrome and symptomatic carotid artery stenosis. PLoS One. 2019; 14(10): e0224210.
  13. Wierzbowska J, Robaszkiewicz J, Figurska M, et al. Future possibilities in glaucoma therapy. Med Sci Monit. 2010; 16(11): RA252–RA259.
  14. Choi EY, Lee SC, Kim M. Optical Coherence Tomography Angiography Before and After Bevacizumab Injection in Ocular Ischemic Syndrome. Retina. 2018; 38(3): e23–e25.
  15. Dzierwa K, Pieniazek P, Musialek P, et al. Treatment strategies in severe symptomatic carotid and coronary artery disease. Med Sci Monit. 2011; 17(8): RA191–RA197.
  16. Kawaguchi S, Iida JI, Uchiyama Y. Ocular Circulation and Chronic Ocular Ischemic Syndrome before and after Carotid Artery Revascularization Surgery. J Ophthalmol. 2012; 2012: 350475.
  17. Tripathy K, Mazumdar S. Recurrent retinal and choroidal ischemia in a case of ocular ischemic syndrome. Ther Adv Ophthalmol. 2019; 11: 2515841419848926.
  18. Fintelmann RE, Rosenwasser RH, Jabbour P, et al. An old problem, a new solution. Surv Ophthalmol. 2010; 55(1): 85–88.
  19. Klijn CJM, Kappelle LJ, van Schooneveld MJ, et al. Venous stasis retinopathy in symptomatic carotid artery occlusion: prevalence, cause, and outcome. Stroke. 2002; 33(3): 695–701.
  20. Hayreh SS, Zimmerman MB. Ocular arterial occlusive disorders and carotid artery disease. Ophthalmol Retina. 2017; 1(1): 12–18.
  21. Mills RP. Anterior segment ischemia secondary to carotid occlusive disease. J Clin Neuroophthalmol . 1989; 9(3): 200–204.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Publisher: VM Media Group sp. z o.o., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 310 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl